Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA accepts for review sNDA for mirabegron in combination with solifenacin for overactive bladder

Sep. 14, 2017

Bayer enters kidney disease collaboration with Vanderbilt University Medical Center

Sep. 12, 2017

MK-3866 studied in patients with impaired renal function

Sep. 12, 2017

Avadel enters license agreement for U.S. and Canadian rights to Noctiva

Sep. 6, 2017

Enrollment completed in phase IIb study of BGS-649 for hypogonadotropic hypogonadism

Sep. 5, 2017

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Sep. 1, 2017

Apricus resubmits Vitaros NDA

Aug. 30, 2017

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

Aug. 30, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

Lilly discovers novel phosphodiesterase PDE1 inhibitors

Aug. 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...